h_fin_2018a_2018-02-26t13:33:53z4 Hearing Summary

Representatives Pabon and Van Winkle, co-prime sponsors, presented House Bill 18-1011, which allows publicly traded companies to invest in medical and retail marijuana businesses and limits which types of investors are subject to disclosure and background investigations.  A strike-below amendment (amendment L.001) was distributed to the committee prior to the hearing [Attachment J].

The bill sponsors responded to committee questions.

Ms. Meg Collins, representing Good Chemistry, testified from a neutral position on the bill.  She responded to questions from the committee.

Ms. Kristi Kelly, representing Marijuana Industry Group, testified in support of the bill.

Mr. Bruce Nassau, representing True Cannabis and Marijuana Industry Group, testified in support of the bill.

Mr. Andy Williams, representing Medicine Man, testified in support of the bill.

Mr. Shawn Coleman, representing Terrapin Care Station, testified in support of the bill.

Mr. Joe Segalia, representing Terra Tech Corp, testified in support of the bill.

Mr. Segalia and Mr. Coleman responded to committee questions.

Representative Pabon commented on witness testimony.

Mr. Dean Heizer, representing LivWell Enlightened Health, testified in support of the bill.

Mr. Michael Drozd, representing Eurofins, testified in support of the bill.

Mr. Jim Burack, Director, Marijuana Enforcement Division within the Department of Revenue, testified from a neutral position on the bill.

Ms. Dominique Mendiola, Deputy Director, Marijuana Enforcement Division, testified from a neutral position on the bill.

Director Burack and Deputy Director Mendiola responded to committee questions. Representative Pabon also responded to a committee question.

The bill was laid over for action only at a later date.